Impact of investigator-assessed response on overall survival (OS) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

Mathews C., Koliadi A., Gilbert L., Slomovitz B. M., Fruhauf F., Buttin B., ...Daha Fazla

ANNALS OF ONCOLOGY, 2024 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1016/j.annonc.2024.08.796
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Hacettepe Üniversitesi Adresli: Evet